Red Light Therapy for Brain Fog & ADHD

Transcranial photobiomodulation (tPBM) — applying near-infrared light to the skull to reach the brain’s outer cortex — is one of the more intriguing frontiers of red light therapy research. For cognitive complaints like brain fog and attention difficulties, the appeal is obvious: a non-invasive, drug-free intervention that directly targets brain metabolism.

The research is genuinely interesting, with plausible mechanisms and some encouraging preliminary data. But it is also early-stage, and the gap between “interesting pilot study” and “proven treatment” is significant. This page reviews the evidence honestly for both brain fog and ADHD, distinguishing between what we know, what we suspect, and what remains speculative.

Understanding Brain Fog

Brain fog is not a clinical diagnosis — it is a descriptive term for a cluster of cognitive symptoms that include:

Difficulty concentrating or maintaining focus
Mental fatigue disproportionate to physical exertion
Slower processing speed
Working memory lapses (forgetting what you were about to say or do)
A subjective sense of mental “cloudiness” or reduced sharpness

Common Causes

Brain fog can arise from numerous underlying conditions:

Sleep deprivation — the single most common cause
Chronic stress and burnout — sustained cortisol elevation impairs prefrontal cortex function
Post-viral syndromes — including long COVID, where brain fog is among the most commonly reported symptoms
Hormonal changes — menopause, thyroid dysfunction, pregnancy
Nutritional deficiencies — iron, vitamin B12, vitamin D
Medications — antihistamines, benzodiazepines, anticholinergics, some antidepressants
Depression and anxiety — cognitive impairment is a core feature of major depression
Neurodegenerative disease — early Alzheimer’s and other dementias can present as “brain fog” before more obvious symptoms emerge

The underlying cause matters enormously for treatment. Red light therapy is not going to fix brain fog caused by iron deficiency or sleep apnoea. Before considering tPBM, address the fundamentals: sleep, nutrition, stress management, and any treatable medical conditions.

The Science of Transcranial PBM

How Light Reaches the Brain

Near-infrared light (typically 810–850 nm) can penetrate the scalp, skull, and meninges to reach the outer cortex of the brain. The degree of penetration depends on:

Wavelength — 810 nm penetrates biological tissue more effectively than shorter wavelengths. It sits in the “optical window” where absorption by haemoglobin, water, and melanin is minimised
Skull thickness — varies by location (thinnest at the temples, thickest at the occiput) and by individual (thicker in men on average)
Hair — acts as a significant barrier. Dark, thick hair absorbs more light than light-coloured or thin hair

Tedford et al. (2015) measured NIR light penetration through human cadaver skulls and found that approximately 2–3% of surface irradiance reaches the cortical surface at 808 nm. While this sounds small, it equates to irradiance levels that have been shown to produce biological effects in cell culture and animal models.

Proposed Mechanisms

The mechanisms by which tPBM may affect brain function are extensions of general PBM biology:

Cytochrome c oxidase (CCO) stimulation — CCO is the primary chromophore for NIR light in the mitochondrial electron transport chain. Brain tissue has exceptionally high mitochondrial density due to the brain’s enormous metabolic demands (the brain consumes roughly 20% of the body’s oxygen despite being 2% of body weight). Stimulating CCO increases ATP production, which could improve neuronal function in metabolically compromised brain tissue.
Cerebral blood flow — Salgado et al. (2015) and Nawashiro et al. (2012) demonstrated that tPBM increases regional cerebral blood flow, potentially improving oxygen and glucose delivery to underperfused areas. This is relevant to brain fog, where reduced prefrontal blood flow has been documented.
Neuroinflammation reduction — tPBM has been shown to reduce neuroinflammatory markers (microglial activation, pro-inflammatory cytokines) in animal models of traumatic brain injury and neurodegeneration. Chronic low-grade neuroinflammation is increasingly implicated in cognitive dysfunction.
Nitric oxide modulation — PBM dissociates nitric oxide from CCO, which can improve mitochondrial efficiency and also promote vasodilation, further enhancing blood flow.

Evidence for Brain Fog and Cognitive Enhancement

Healthy Adults

Barrett and Bhatt Gonzalez (2013) conducted a randomised, sham-controlled study applying 1064 nm laser tPBM to the right forehead of healthy young adults. The treatment group showed improved performance on sustained attention tasks and working memory (measured by the Psychomotor Vigilance Task and a delayed match-to-sample test). This was one of the first human studies suggesting tPBM could enhance cognition in healthy individuals.

Blanco et al. (2017) replicated and extended these findings using 1064 nm tPBM to the right prefrontal cortex. They found improvements in executive function tasks (Wisconsin Card Sorting Test) in healthy university students. The effects were modest but statistically significant.

Zhao et al. (2022) published a systematic review of tPBM for cognitive enhancement in healthy adults in Ageing Research Reviews. The pooled analysis suggested small but consistent improvements in attention, working memory, and executive function. The authors noted that study quality was variable and called for larger, more rigorous trials.

Long COVID Brain Fog

Longo et al. (2023) reported a case series of 19 patients with persistent cognitive symptoms following COVID-19, treated with intranasal and transcranial PBM (810 nm). Patients showed improvements in self-reported cognitive function, fatigue, and quality of life measures after 12 weeks of treatment. However, this was an uncontrolled case series — the placebo effect and natural recovery cannot be ruled out.

Figueiro Longo et al. (2022) published a pilot study in the Journal of Photochemistry and Photobiology B using tPBM for long COVID cognitive symptoms. Ten patients received twice-weekly tPBM for 8 weeks. Neuropsychological testing showed improvements in processing speed and executive function. Again, the small sample size and lack of a control group limit conclusions.

The long COVID evidence is promising but preliminary. Larger randomised trials are underway, and results are needed before tPBM can be recommended as a standard treatment.

Evidence for ADHD

ADHD (attention-deficit/hyperactivity disorder) involves dysfunction in prefrontal cortex networks governing attention, impulse control, and executive function. The prefrontal cortex is readily accessible to tPBM through the forehead, making it a logical target.

The Biological Rationale

Prefrontal hypoactivation — functional neuroimaging consistently shows reduced prefrontal cortex activity in ADHD, particularly during tasks requiring sustained attention and executive control. tPBM could theoretically upregulate prefrontal metabolism
Dopaminergic pathways — some animal studies suggest PBM may modulate dopamine signalling, though the evidence is very preliminary
Mitochondrial dysfunction — emerging evidence suggests mitochondrial dysfunction may contribute to ADHD pathophysiology in some individuals

Clinical Evidence

Mosilhy et al. (2022) published a review in Photobiomodulation, Photomedicine, and Laser Surgery examining the potential of tPBM for ADHD. They concluded that the rationale was “compelling” based on the known mechanisms of tPBM and the neurobiology of ADHD, but noted that direct clinical evidence was limited to case reports and pilot studies.

Cassano et al. (2019) reported positive effects of tPBM on executive function and depressive symptoms in patients with major depressive disorder — a condition with significant symptom overlap with ADHD (concentration difficulties, working memory impairment, executive dysfunction). While not an ADHD study, the improvements in overlapping cognitive domains are relevant.

The honest position on ADHD: There are no published RCTs of tPBM specifically for ADHD. The biological rationale is plausible, and the general cognitive enhancement literature is encouraging, but we cannot say that tPBM is an evidence-based treatment for ADHD at this time. Anyone with ADHD should work with their clinician on established treatments (behavioural strategies, medication where appropriate) and consider tPBM only as a potential adjunct, not an alternative.

Protocol for Transcranial PBM

If you want to try tPBM for cognitive symptoms, here is a protocol based on the available research:

Wavelength

810 nm (near-infrared) — the most commonly used wavelength in tPBM research
850 nm is a reasonable alternative
Red light (630–660 nm) does not penetrate the skull adequately and should not be used for transcranial applications

Target Area

Forehead (prefrontal cortex) — the primary target for attention, working memory, and executive function
Position the device centrally on the forehead, approximately 2–3 cm above the eyebrows
Some protocols also target the temporal regions (above and in front of the ears) and the posterior scalp (over the default mode network)

Dose

Irradiance at the scalp surface: 50–250 mW/cm²
Energy density: 10–30 J/cm² at the scalp surface (this delivers approximately 0.2–0.9 J/cm² at the cortical surface, accounting for ~3% penetration)
Treatment time: 8–20 minutes per session depending on device output

Frequency

3–5 sessions per week
Minimum 4-week trial for cognitive effects (most studies assess outcomes at 4–12 weeks)
Some acute effects (temporary improvements in attention) have been reported after single sessions, but sustained benefits require consistent use

Important Safety Notes

Eye protection is not typically needed for forehead application, but avoid shining the light directly into the eyes
Start with shorter sessions (5–8 minutes) and increase gradually
Do not use tPBM if you have a history of seizures — the evidence for seizure risk is weak, but it has not been ruled out
Stop if you experience headaches, agitation, or insomnia after sessions — these have been reported occasionally and may indicate overstimulation
Pulse frequency matters in some research — some tPBM studies use 40 Hz pulsing (gamma frequency), which may have additional neurological effects. Most home devices use continuous wave (CW) mode, which is what the majority of positive studies have used

Device Considerations

What Works

LED panels with 810–850 nm NIR — position the panel close to the forehead. Any mid-to-large panel with adequate NIR output will work
Dedicated tPBM devices — purpose-built transcranial devices exist (e.g., Vielight, which has been used in several clinical studies). These are designed specifically for brain applications with appropriate wavelengths and dosing
LED headbands/caps — some devices are designed to wrap around the head, providing multi-point scalp coverage

What Does Not Work

Red-only devices (630–660 nm) — insufficient skull penetration
LED face masks — designed for skin treatment, typically lack adequate NIR output for transcranial effects
Devices worn over thick hair — dark or thick hair absorbs significant NIR energy. Part the hair or shave the treatment area for better penetration

Realistic Expectations

Scenario	Likely Benefit	Evidence Level
General brain fog (after addressing underlying causes)	Modest improvement in focus and clarity	Low-Moderate
Long COVID cognitive symptoms	Possible benefit	Low (pilot data only)
ADHD (as adjunct to standard treatment)	Unknown — plausible but unproven	Very Low
Healthy adults seeking cognitive edge	Small, measurable improvements in lab tasks	Moderate

The Honest Assessment

Transcranial PBM for cognitive function is one of the more scientifically interesting areas of photobiomodulation research. The mechanisms are plausible, the preliminary data is encouraging, and the safety profile appears favourable.

But this is firmly in the “promising early research” category, not “proven treatment.” If you have brain fog, the first step is identifying and addressing the underlying cause — whether that is poor sleep, nutritional deficiency, chronic stress, or a medical condition. tPBM makes the most sense as an adjunct once the fundamentals are optimised.

For ADHD specifically, the evidence is too preliminary to make any recommendations. If you or your child has ADHD, work with a qualified clinician on established treatment approaches. tPBM may eventually prove to be a useful add-on, but that has not yet been demonstrated.

The technology is safe and the approach is reasonable — just keep your expectations calibrated to the evidence rather than the marketing.

This article is for informational purposes only and does not constitute medical advice. Brain fog can be a symptom of serious medical conditions. If you experience persistent cognitive difficulties, consult a healthcare professional for proper evaluation. ADHD should be assessed and managed by a qualified clinician.